From: Prioritising Cochrane reviews to be updated with health equity focus
13 conditions for which we found reviews | No. reviews | Review title* | Year of current review version |
---|---|---|---|
Antiretroviral therapy coverage | 2 | Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women | 2010 |
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults | 2010 | ||
Breast Cancer | 2 | Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients | 2012 |
Trastuzumab containing regimens for early breast cancer | 2012 | ||
Cervical Cancer | 3 | Adjuvant platinum-based chemotherapy for early stage cervical cancer | 2016 |
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males | 2019 | ||
Extended-field radiotherapy for locally advanced cervical cancer | 2018 | ||
Chagas Disease | 1 | Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection | 2014 |
Chronic kidney disease | 3 | Interventions for idiopathic steroid-resistant nephrotic syndrome in children | 2019 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome | 2021 | ||
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD) | 2018 | ||
Chronic obstructive pulmonary disease treatment | 5 | Hospital at home for acute exacerbations of chronic obstructive pulmonary disease | 2012 |
Indacaterol, a once-daily beta2-agonist versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary disease | 2015 | ||
Antibiotics for exacerbations of chronic obstructive pulmonary disease | 2018 | ||
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease | 2017 | ||
Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease | 2020 | ||
Colon and rectum cancer treatment | 2 | Strategies for detecting colon cancer in patients with inflammatory bowel disease | 2017 |
Second-line systemic therapy for metastatic colorectal cancer | 2017 | ||
Diphtheria-tetanus-pertussis vaccine coverage | 1 | Vaccines for women for preventing neonatal tetanus | 2015 |
Ischaemic heart disease | 2 | Exercise-based cardiac rehabilitation for coronary heart disease | 2021 |
Hyperbaric oxygen therapy for acute coronary syndrome | 2015 | ||
Lower respiratory infections | 3 | Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection | 2015 |
Corticosteroids for pneumonia | 2017 | ||
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients | 2014 | ||
Malaria | 5 | Intermittent preventive treatment for malaria in children living in areas with seasonal transmission | 2012 |
Artemether for severe malaria | 2019 | ||
Artesunate versus quinine for treating severe malaria | 2012 | ||
Home- or community‐based programmes for treating malaria | 2013 | ||
Insecticide-treated nets for preventing malaria | 2018 | ||
Stroke | 2 | Carotid endarterectomy for symptomatic carotid stenosis | 2020 |
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack | 2019 | ||
Tuberculosis | 2 | Interventions for treating tuberculous pericarditis | 2017 |
Isoniazid for preventing tuberculosis in HIV-infected children | 2017 |